title: Characterization of ovarian cancer cell lines as in vivo models for preclinical studies.
abstract: The value of cell lines for pre-clinical work lies in choosing those with similar characteristics. Selection of cell lines is typically based on patient history, histological subtype at diagnosis, mutation patterns, or signaling pathways. Although recent studies established consensus regarding molecular characteristics of ovarian cancer cell lines, data on in vivo tumorigenicity remains only sporadically available, impeding translation of in vitro work to xenograft models.
  
  
  
  We introduced 18 ovarian cancer cell lines into athymic nude mice through subcutaneous, intraperitoneal, and ovary intrabursal routes, and observed tumor development over 6weeks. We also profiled cell line gene expression and identified differentially expressed gene sets based on their ability to form tumors in the subcutaneous or intraperitoneal locations. Representative cell lines were further subjected to proteomic analyses.
  
  
  
  Ovarian cancer cell lines showed variable ability to grow in mice when implanted subcutaneous, intraperitoneal, or intrabursal. While some cell lines grew well in both SC and IP locations, others showed a strong propensity to grow in one location only. Gene expression profiles suggested that cell lines showing preference for IP growth had gene expression patterns more similar to primary tumors.
  
  
  
  We report the tumorigenicity of 17 human ovarian cancer cell lines and one mouse cell line in three distinct anatomical locations, and associated gene networks. Growth patterns and histopathology, linked to molecular characteristics, provide a valuable resource to the research community, and better guide the choice of cell lines for in vitro studies to translate efficiently into xenograft testing.
authors.affiliation: Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, United States.
authors.forename: Lidia
authors.initials: L
authors.lastname: Hernandez
authors.affiliation: Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, United States.
authors.forename: Marianne K
authors.initials: MK
authors.lastname: Kim
authors.affiliation: Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, United States.
authors.forename: L Tiffany
authors.initials: LT
authors.lastname: Lyle
authors.affiliation: Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, United States.
authors.forename: Kristen P
authors.initials: KP
authors.lastname: Bunch
authors.affiliation: Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, United States.
authors.forename: Carrie D
authors.initials: CD
authors.lastname: House
authors.affiliation: Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, United States.
authors.forename: Franklin
authors.initials: F
authors.lastname: Ning
authors.affiliation: Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, United States.
authors.forename: Anne M
authors.initials: AM
authors.lastname: Noonan
authors.affiliation: Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, United States. Electronic address: annunzic@mail.nih.gov.
authors.forename: Christina M
authors.initials: CM
authors.lastname: Annunziata
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D004354:Drug Screening Assays, Antitumor / Q000379:methods*; D005260:Female; D064593:Heterografts; D006801:Humans; D051379:Mice; D009368:Neoplasm Transplantation; D010051:Ovarian Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D023041:Xenograft Model Antitumor Assays / Q000379:methods*
keywords: Cell lines; Mouse model; Ovarian cancer; Xenografts